Drug Trial Radar · NCT06668805
A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment
Last checked: Nov 20, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
18
Actual
Start
Nov 22, 2024
Primary completion
Sep 16, 2026
Study completion Oct 16, 2026
Sponsor
- Lead sponsor
- BioMarin PharmaceuticalBioMarin (BMRN)
- Sponsor type
- Industry
- First posted
- Oct 31, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 3 years, up to 11 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study in children with Noonan syndrome is to evaluate the effect of 3 doses of vosoritide on growth as measured by AGV after 6 months of treatment. The long-term efficacy and safety of vosoritide at the therapeutic dose will be evaluated up to FAH.
Conditions
- Noonan Syndrome
Interventions
Vosoritide InjectionDrug
Modified recombinant human C-type natriuretic peptide Vosoritide
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in Annualized Growth Velocity (AGV)Time frame: At 6 months
Locations
38 sites in 7 countries. Site status is shown where the registry gives one.
Childrens Hospital Los Angeles
Los Angeles, California
Children's Hospital of Orange County Main Campus - Orange
Orange, California
Children's Hospital Colorado
Aurora, Colorado
Nemours Children's Hospital, Delaware (Alfred I. Dupont Hospital for Children)
Wilmington, Delaware
Children's National Medical Center
Washington D.C., District of Columbia
Nicklaus Children's Hospital
Miami, Florida
Emory University School of Medicine
Atlanta, Georgia
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois
Riley Hospital for Children at Indiana University Health
Indianapolis, Indiana
University of Iowa
Iowa City, Iowa
Kentucky Children's Hospital
Lexington, Kentucky
New York Medical College
Boston, Massachusetts
Icahn School of Medicine at Mount Sinai
New York, New York
Children's Hospital at Montefiore
The Bronx, New York
Atrium Health Carolinas Medical Center
Charlotte, North Carolina
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio
Childrens Hospital of Philadelphia
Philadelphia, Pennsylvania
Vanderbilt University Medical Center
Nashville, Tennessee
Children's Medical Center Dallas
Dallas, Texas
University of Texas Health Science Center at Houston (UT Health)
Houston, Texas
Froedtert & Medical College of Wisconsin
Milwaukee, Wisconsin
Royal North Shore Hospital
Saint Leonards, New South Wales, Australia
Childrens Health Queensland Hospital and Health Service
South Brisbane, Queensland, Australia
Murdoch Children's Research Institute
Parkville, Victoria, Australia
M.A.G.I.C. Clinic
Calgary, Alberta, Canada
SickKids - The Hospital for Sick Children
Toronto, Ontario, Canada
Centre Hospitalier Universitaire Sainte-Justine
Montreal, Quebec, Canada
Hôpital de la Timone
Marseille, Bouches-du-Rhône, France
Angers University Hospital Center
Angers, Maine-et-Loire, France
CHU de Toulouse - Hôpital des Enfants
Toulouse, Occitanie, France
South Paris University Hospitals - Bicetre Hospital
Le Kremlin-Bicêtre, Paris, France
Hôpital Robert-Debré
Paris, Paris, France
Universitätsklinikum des Saarlandes
Homburg, Saarland, Germany
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Roma, Italy
Azienda Ospedaliero Universitaria - Ospedale Pediatrico Meyer
Florence, Florence, Italy
IRCCS Istituto Giannina Gaslini
Genova, Genoa, Italy
Hospital Clínico Universitario de Santiago
Santiago de Compostela, La Coruña, Spain
Central University Hospital of Asturias
Oviedo, Principality of Asturias, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.